1. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway


    Xue-zhen Song et al, 2020, OncoTargets and Therapy CrossRef
  2. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis
    Dengbao Li et al, 2020, Pathobiology CrossRef
  3. Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest
    Yikai Wang et al, 2023, Canadian Journal of Gastroenterology and Hepatology CrossRef
  4. Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
    Peng Huang et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  5. Long Non-Coding RNA MAFG-AS1 Regulates the Proliferation and Epithelial to Mesenchymal Transition of Human Esophageal Carcinoma Cells
    Shuhong Kang et al, 2024, International Journal of Pharmacology CrossRef
  6. Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile
    Yuanyuan Tian et al, 2022, Frontiers in Surgery CrossRef

  7. LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis


    Cui-juan Qian et al, 2020, Cancer Management and Research CrossRef